Nashville, Tenn., Oct. 29 (HSMN NewsFeed) — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) and Phebra Pty Ltd., an Australian-based specialty pharma company, today announced they have entered into an exclusive partnership for the commercializat…
Biopharmaceuticals
Cumberland Pharmaceuticals, Phebra, Caldolor, ibuprofen

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand”
Leave a Comment